Artificial Intelligence

After a $40M sale and a massive stock buyback, DTST is pivoting to AI continuity, a niche but critical market for regulated industries. Is it a masterstroke?

Lightpath is building a 392-mile fiber network linking two of the world's fastest-growing data hubs, a major bet on the future of AI infrastructure.

University of Michigan Health is the first in the Midwest to use Unfold AI, a new platform creating 3D cancer maps to personalize patient treatment.

From nano-surfactants to pharmaceuticals, SureNano Science is betting its future on a novel obesity drug. Can this microcap survive the big leagues?

Thinkfree's new AI Web Office promises secure, editable documents from AI, keeping sensitive enterprise data safely off the public cloud. Here's why.

Two neurotech giants are creating an open ecosystem for AI in brain imaging, aiming to speed up diagnostics for epilepsy, tumors, and brain injury.

At COMPUTEX 2026, OWC is set to unveil a full suite of Thunderbolt 5 gear, promising to redefine high-speed workflows for Mac and PC professionals.

A new partnership brings high-tech, low-cost car key duplication to 600+ Sam's Club locations, threatening the expensive dealership model with AI-powered kiosks.

A new platform combines real-time physiological and gas monitoring, promising a proactive shift in safety for workers in the most hazardous industries.

Hong Kong security firm SU Group is raising $6M via a complex warrant offering, stirring investor debate on whether it's for growth or a financial lifeline.

A new platform offers hardware-free crypto participation amid wild $310K Bitcoin forecasts, but questions about the company and its tech remain.

A new conversational AI tool from Mashvisor lets investors ask plain-English questions about rental properties, promising to slash research time by 80%.

The new platform integrates public records requests from intake to delivery, promising to ease the burden on agencies facing massive backlogs.

A new CISO-voted list reveals the 30 startups trusted to secure the AI era as a new report warns that AI adoption is dangerously outpacing security readiness.

Online sellers in coaching and supplements face account freezes. A new service says prevention is key, offering stable processing for at-risk businesses.

ODAIA's new AI platform moves beyond static segments to treat each doctor as a 'segment of one,' promising to boost engagement and slash marketing waste.

Risk management leader Crisis24 hits AWS Marketplace, letting firms use committed cloud spend for its AI-powered security and intelligence platform.

Response Pharmaceuticals unveils promising data on RDX-002, a first-in-class drug aimed at preventing a severe side effect of essential mental health drugs.

From lab breakthroughs to Hollywood advocacy, the 2026 Reeve Summit showcases a powerful, multi-front strategy to cure paralysis and enrich lives today.

Arvinas secures a historic first FDA approval for a PROTAC drug and inks a deal to fuel a deep pipeline targeting cancer and neurodegenerative diseases.